Based on the above results, it is speculated that Notch1 gene might play a key role in glioma TMZ resistance, while ARV‐825 could degrade BRD4 protein to reverse glioma TMZ resistance by modulating Notch1 pathway related genes expression. This evidence concerns the gene BRD4 and central nervous system cancer.